Transgelin in Bladder Cancer: A Potential Biomarker and Therapeutic Target

EBioMedicine - Netherlands
doi 10.1016/j.ebiom.2019.09.011
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

C-Met as a Potential Therapeutic Target and Biomarker in Cancer

Therapeutic Advances in Medical Oncology
Oncology
2011English

MiR-30a: A Novel Biomarker and Potential Therapeutic Target for Cancer

Journal of Oncology
Oncology
2018English

Surfactant Protein D as a Potential Biomarker and Therapeutic Target in Ovarian Cancer

Frontiers in Oncology
Cancer ResearchOncology
2019English

The Phosphatidylinositol 3-Kinase Pathway as a Potential Therapeutic Target in Bladder Cancer

Clinical Cancer Research
Cancer ResearchOncology
2017English

EZH2 in Bladder Cancer, a Promising Therapeutic Target

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2015English

Bladder Cancer-Associated Protein, a Potential Prognostic Biomarker in Human Bladder Cancer

Molecular and Cellular Proteomics
BiochemistryMedicineAnalytical ChemistryMolecular Biology
2009English

The PREX1/Rac Signaling Axis: Potential as a Biomarker and Therapeutic Target in Breast Cancer

Molecular and Cellular Oncology
Cancer ResearchMolecular Medicine
2015English

EGFR Family Inhibition Identifies P38 MAPK as a Potential Therapeutic Target in Bladder Cancer

Urology
Urology
2018English

Glycoprotein-130 Expression Is Associated With Aggressive Bladder Cancer and Is a Potential Therapeutic Target

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy